Other reports

Compensation for the Supervisory Board members in fiscal year 2022

The compensation of the Supervisory Board members is defined by article 20 of the Articles of Association of Merck KGaA, Darmstadt, Germany, and corresponds to the compensation system for the Supervisory Board that was adopted by the 2022 Annual General Meeting with 99.64% of the votes cast.

Accordingly, the members of the Supervisory Board receive fixed compensation of € 47,000 per year. The Chairman receives double, and the Vice Chairman receives one and a half times this amount. In addition to their fixed compensation, Supervisory Board members who are also members of the Audit Committee, which has been established in the meeting of the Supervisory Board on February 26, 2021, receive annual compensation of € 15,000. The Chair of the Audit Committee receives an additional annual compensation of € 30,000. Moreover, the members receive an additional compensation of € 750 per meeting they attend.

The compensation awarded or due and the respective relative share of the total compensation for the current members of the Supervisory Board is presented in the following table. During the fiscal year, Edeltraud Glänzer resigned from the Supervisory Board effective May 15, 2022, and Birgit Biermann joined the Supervisory Board effective July 14, 2022. There were no payments to former members of the Supervisory Board in the fiscal year.

Compensation awarded or due

 

 

2022

 

2021

 

 

Fixed compensation

 

Compensation for commit­tee duties

 

Meeting fees

 

Total compen­sation

 

Fixed compensation

 

Compensation for committee duties

 

Meeting fees

 

Total compen­sation

 

 

€
thous­and

 

in %

 

€
thou­sand

 

in %

 

€
thou­sand

 

in %

 

€
thou­sand

 

€
thou­sand

 

in %

 

€
thou­sand

 

in %

 

€
thou­sand

 

in %

 

€
thou­sand

Wolfgang Büchele

 

94.0

 

84%

 

15.0

 

13%

 

3.0

 

3%

 

112.0

 

94.0

 

86%

 

12.7

 

12%

 

3.0

 

3%

 

109.7

Sascha Held

 

70.5

 

80%

 

15.0

 

17%

 

3.0

 

3%

 

88.5

 

70.5

 

82%

 

12.7

 

15%

 

3.0

 

4%

 

86.2

Gabriele Eismann

 

47.0

 

94%

 

–

 

–

 

3.0

 

6%

 

50.0

 

47.0

 

94%

 

–

 

–

 

3.0

 

6%

 

50.0

Edeltraud Glänzer
(until May 15, 2022)

 

17.4

 

71%

 

5.5

 

23%

 

1.5

 

6%

 

24.4

 

47.0

 

75%

 

12.7

 

20%

 

3.0

 

5%

 

62.7

Birgit Biermann
(since July 14, 2022)

 

22.0

 

94%

 

–

 

–

 

1.5

 

6%

 

23.5

 

–

 

–

 

–

 

–

 

–

 

–

 

–

Jürgen Glaser

 

47.0

 

79%

 

9.5

 

16%

 

3.0

 

5%

 

59.5

 

47.0

 

95%

 

–

 

–

 

2.3

 

5%

 

49.3

Michael Kleinemeier

 

47.0

 

94%

 

–

 

–

 

3.0

 

6%

 

50.0

 

47.0

 

94%

 

–

 

–

 

3.0

 

6%

 

50.0

Renate Koehler

 

47.0

 

94%

 

–

 

–

 

3.0

 

6%

 

50.0

 

47.0

 

94%

 

–

 

–

 

3.0

 

6%

 

50.0

Anne Lange

 

47.0

 

94%

 

–

 

–

 

3.0

 

6%

 

50.0

 

47.0

 

94%

 

–

 

–

 

3.0

 

6%

 

50.0

Peter Emanuel Merck

 

47.0

 

94%

 

–

 

–

 

3.0

 

6%

 

50.0

 

47.0

 

94%

 

–

 

–

 

3.0

 

6%

 

50.0

Dietmar Oeter

 

47.0

 

94%

 

–

 

–

 

3.0

 

6%

 

50.0

 

47.0

 

94%

 

–

 

–

 

3.0

 

6%

 

50.0

Alexander Putz

 

47.0

 

94%

 

–

 

–

 

3.0

 

6%

 

50.0

 

47.0

 

94%

 

–

 

–

 

3.0

 

6%

 

50.0

Christian Raabe

 

47.0

 

72%

 

15.0

 

23%

 

3.0

 

5%

 

65.0

 

47.0

 

75%

 

12.7

 

20%

 

3.0

 

5%

 

62.7

Helene von Roeder

 

47.0

 

59%

 

30.0

 

38%

 

3.0

 

4%

 

80.0

 

47.0

 

62%

 

25.4

 

34%

 

3.0

 

4%

 

75.4

Helga Rübsamen-Schaeff

 

47.0

 

94%

 

–

 

–

 

3.0

 

6%

 

50.0

 

47.0

 

94%

 

–

 

–

 

3.0

 

6%

 

50.0

Daniel Thelen

 

47.0

 

72%

 

15.0

 

23%

 

3.0

 

5%

 

65.0

 

47.0

 

75%

 

12.7

 

20%

 

3.0

 

5%

 

62.7

Simon Thelen

 

47.0

 

94%

 

–

 

–

 

3.0

 

6%

 

50.0

 

47.0

 

94%

 

–

 

–

 

3.0

 

6%

 

50.0

Supervisory Board member Wolfgang Büchele received an additional € 140,000 (2021: € 140,000) for 2022 in this function as a member of the corporate bodies of E. Merck KG, Darmstadt, Germany.

Supervisory Board member Helga Rübsamen-Schaeff received an additional € 150,000 (2021: € 150,000) for 2022 in this function as a member of the corporate bodies of E. Merck KG, Darmstadt, Germany, and an additional € 6,000 (2021: € 6,000) for 2022 as a member of the Supervisory Board of Merck Healthcare KGaA, Darmstadt, Germany, a subsidiary of Merck KGaA, Darmstadt, Germany.

Supervisory Board member Michael Kleinemeier received an additional € 140,000 (2021: € 140,000) as a member of committees of E. Merck KG, Darmstadt, Germany, for 2022 in this function.

Supervisory Board member Helene von Roeder received an additional € 150,000 (2021: € 150,000) for 2022 in this function as a member of the corporate bodies of E. Merck KG, Darmstadt, Germany.

Supervisory Board member Peter Emanuel Merck received an additional € 80,000 (2021: € 80,000) for 2022 in this function as a member of the corporate bodies of E. Merck KG, Darmstadt, Germany.

Supervisory Board member Daniel Thelen received an additional € 140,000 for 2022 in this function as a member of the corporate bodies of E. Merck KG, Darmstadt, Germany (2021: € 140,000).

Supervisory Board member Simon Thelen received an additional € 140,000 (2021: € 140,000) for 2022 in this function as a member of the corporate bodies of E. Merck KG, Darmstadt, Germany, and an additional € 3,000 (2021: € 3,000) for 2022 as a member of the Supervisory Board of Merck Healthcare KGaA, Darmstadt, Germany, a subsidiary of Merck KGaA, Darmstadt, Germany.

Share this page: